PDF herunterladen
Thromb Haemost 1999; 81(05): 852
DOI: 10.1055/s-0037-1614585
Letters to the Editor
Schattauer GmbH

Is a Change of Factor VIII Product a Risk Factor for the Development of a Factor VIII Inhibitor?

Thynn Thynn Yee
1   From the Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Department of Haematology, Royal Free and University College Medical School, University College London, U.K.
,
C. A. Lee
1   From the Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Department of Haematology, Royal Free and University College Medical School, University College London, U.K.
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 31. Dezember 1998

Accepted 08. Februar 1999

Publikationsdatum:
09. Dezember 2017 (online)

Auch verfügbar auf
    Lizenzen und Reprints

 

 

  • References

  • 1 Baglin T, Beacham E.. Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor? Thromb Haemost. 1998; 80:: 1036-7.
    PubMedSuche in Google Scholar
  • 2 Yee TT, Lee CA, Riddel A, Pasi KJ. From Tolerance to Intolerance of factor VIII: A Clinical Case Presentation. C.M.E.. Bulletin 1997; 1: 16-7.
    PubMedSuche in Google Scholar
  • 3 Antonarakis SE, Kazazian HH, Gitschier J, Hutter P, de Moerloose P, Morris MA. Molecular etiology of factor VIII deficiency in haemophilia A. Advances in experimental medicine and biology.. Ed by Aledort L. M., Hoyer L. W., Lusher J. M., Reisner H. M., and C. G.. White II. 1996; 386: 19-34.
    PubMedSuche in Google Scholar
  • 4 Lee CA. Investigation of chronic hepatitis C infection in individuals with haemophilia.. Br J Haematol 1997; 96: 425
    CrossrefPubMedSuche in Google Scholar